Search

Aim of the study : The authors present a novel and specific controlled ovarian stimulation protocol for fertility preservation in women with estrogen-positive receptor breast cancer undergoing neoadjuvant chemotherapy. The protocol foresees random start ovarian stimulation and the use of letrozole associated to tamoxifen. Material and methods : Forty breast cancer patients were included in the study. COS was performed either with recombinant FSH or hMG. Concomitantly with COS, letrozole in a dose of 5 mg and tamoxifen in a dose of 20 mg were given orally on a daily basis. The trigger was performed with 0.2 mg of triptorelin, in the presence of follicles ≥ 19 mm. Oocyte retrieval was scheduled 35–36 hours after triptorelin injection. Our main outcome measures were the number of oocytes collected and number of oocytes vitrified, the length of ovarian stimulation, total dose of gonadotropins administered, and levels of estradiol on the day of the trigger. Results : The mean age of patients was 30.43 ±4.25 years. Nineteen women commenced COS in the luteal phase, eleven in the early follicular phase and ten in the late follicular phase. The mean number of collected oocytes was 11.78 ±9.12 and the mean number of vitrified oocytes was 9.72 ±7.36. The mean duration of COS was 10.03 ±1.33 days. The mean estradiol concentrations on the triggering day was 623.10 ±441.27, and the mean dose of gonadotropins administered was 2540 ±713.10. Conclusions : The authors suggest that the protocol is efficient and may be a safe option for oocyte vitrification in these patients.

OBJECTIVE To evaluate, by a literature review, the Timed "Up & Go" (TUG) test use and its main methodological aspects in children and adolescents. DATA SOURCES The searches were performed in the following databases: PubMed, CINAHL, Web of Science, SciELO and Cochrane Library, from April to July 2012. Studies published from 1990 to 2012 using the terms in Portuguese and English "Timed "Up & Go", "test", "balance", "child", and "adolescent" were selected. The results were divided into categories: general characteristics of the studies, population, test implementation METHODS, interpretation of results and associations with other measurements. DATA SYNTHESIS 27 studies were analyzed in this review and most of them used the TUG test along with other outcome measures to assess functional mobility or balance. Three studies evaluated the TUG test in significant samples of children and adolescents with typical development, and the most studied specific diagnoses were cerebral palsy and traumatic brain injury. The absence of methodological standardization was noted, but one study proposed adaptations to the pediatric population. In children and adolescents with specific clinical diagnoses, the coefficient of within-session reliability was found to be high in most studies, as well as the intra and inter-examiner reliability, which characterizes the good reproducibility of the test. CONCLUSIONS The TUG test was shown to be a good tool to assess functional mobility in the pediatric population, presenting a good reproducibility and correlation with other assessment tools.

OBJETIVO: comparar as informações obtidas pela ultra-sonografia pélvica e transvaginal (USG), histerossalpingografia (HSG), histeroscopia diagnóstica (HSC), ressonância nuclear magnética pélvica (RNMP) e hísterossonografia tridimensional (HSSNG 3D) para melhorar a acurácia e simplificar a investigação do fator uterino cervical e corporal em infertilidade conjugal. MÉTODOS: no período de janeiro a julho de 2003, cinquenta mulheres com queixa de infertilidade de, no mínimo, dois anos foram submetidas a USG, HSG, HSC, RNMP e HSSNG 3D como exames de rastreamento para o diagnóstico do fator uterino. Foram analisados o canal endocervical, endométrio, miométrio e presença de malformações uterinas. Os resultados de cada exame foram analisados e comparados. RESULTADOS: das 50 mulheres incluídas, 12 (24%) apresentaram alteração em pelo menos um dos exames realizados. Quando se comparou a HSSNG 3D com a USG, a HSSNG 3D forneceu informações adicionais em 7 casos (58,3%); comparada com a HSG, forneceu informações adicionais em 7 casos (58,3%); com a HSC, em 4 casos (32,1%), e comparada à RNPM, em 6 casos (50%). Somente em dois casos a HSG detectou alterações do canal endocervical que não foram visualizadas na HSSNG 3D; em todos os outros casos a HSSNG 3D forneceu o mesmo diagnóstico ou deu informações adicionais em relação aos outros exames. A análise pelo teste kappa mostrou que existe concordância entre os diagnósticos obtidos com o uso da HSSNG 3D e a USG, HSG e RNMP. No entanto, quando se associaram os resultados da HSG e da HSSNG 3D observamos que todas as condições clínicas poderiam ter sido diagnosticadas, de forma precisa, somente com esses exames. CONCLUSÃO: a associação da HSG com a HSSNG 3D pode ser suficiente para o diagnóstico do fator uterino cervical e corporal em infertilidade, reduzindo o número de exames realizados por cada paciente, os custos totais finais, a ansiedade e o retardo para o início do tratamento.PURPOSE: to compare the information obtained with pelvic and transvaginal ultrasonography (USG), hystero-salpingography (HSG), diagnostic hysteroscopy (HSC), pelvic nuclear magnetic resonance imaging (PNMR), three-dimensional hysterosonography (3D HSSNG), to optimize and simplify the investigation about cervical and corporeal uterine factors in conjugal infertility. METHODS: in the period between January and July 2003, fifty women reporting infertility for at least two years were submitted to USG, HSG, HSC, PNMR, and 3D HSSNG as tracking examinations for uterine factor diagnosis. The endocervical canal, as well as the endometrium, myometrium, and the presence of uterine malformations were investigated. The results of each examination were analyzed and compared. RESULTS: of the 50 women studied, 12 (24%) presented alteration in at least one of the examinations. When 3D HSSNG was compared to USG, 3D HSSNG provided additional information in 7 cases (58.3%); when compared to HSG, it provided additional information in 7 cases (58.3%); when compared to HSC, it provided additional information in 4 cases (32.1%), and when compared to PNMR, it provided additional information in 6 cases (50%). There were only two cases in which HSG detected alterations of the endocervical canal that were not visualized using 3D HSSNG. In the other cases 3D HSSNG imparted the same diagnosis; furthermore, it provided additional information in comparison to the other examinations. Statistical analysis using the kappa test demonstrated that the diagnoses obtained by 3D HSSNG were in agreement with those obtained with USG, HSG and PNMR (p